Latest News about Gilead Sciences Inc
Recent news which mentions Gilead Sciences Inc
   Trump's drug price ultimatum sets pharma firms scrambling
   
  
  August 01, 2025
  From CNBC.com News
 From CNBC.com News
 
   Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
   
  
  July 08, 2025
  From CNBC.com News
 
   FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
   
  
  June 18, 2025
  From CNBC.com News
 
   Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
   
  
  June 17, 2025
  From CNBC.com News
 
   Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
   
  
  June 03, 2025
  From CNBC.com News
 
   Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know
   
  
  May 12, 2025
  From CNBC.com News
 
   Corporate America shelled out millions for Trump's inauguration. Now he's upending many of their businesses
   
  
  April 23, 2025
  From CNBC.com News
 
   Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
   
  
  April 01, 2025
  From CNBC.com News
 
   U.S. investors, Big Pharma race to find new medicines in China
   
  
  February 13, 2025
  From CNBC.com News
 
   Salesforce picks board member Robin Washington to be its next finance and operating leader
   
  
  February 05, 2025
  From CNBC.com News
 
   Friday's big stock stories: What’s likely to move the market in the next trading session
   
  
  November 07, 2024
  From CNBC.com News
 
   5 things to know before the stock market opens Friday
   
  
  September 13, 2024
  From CNBC.com News
 
   Gilead's twice-yearly shot cut HIV infections by 96% in trial
   
  
  September 12, 2024
  From CNBC.com News
 
   Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit
   
  
  August 16, 2024
  From CNBC.com News
 
   Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
   
  
  July 03, 2024
  From CNBC.com News
 
   Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
   
  
  June 26, 2024
  From CNBC.com News
 
   5 things to know before the stock market opens Friday
   
  
  June 21, 2024
  From CNBC.com News
 From CNBC.com News
 From Business Journals
 From Business Journals
 
   Gilead stock falls after disappointing lung cancer study results
   
  
  January 22, 2024
  From CNBC.com News
 
   Fraud in a bottle: How Big Pharma takes on criminals who make millions off counterfeit drugs
   
  
  
  December 11, 2023
  From CNBC.com News
 
   Miami man pleads guilty to selling adulterated, misbranded HIV drugs across United States
   
  
  
  September 26, 2023
  From CNBC.com News
 
   Stocks making the biggest moves midday: Kroger, DocuSign, Planet Labs, First Solar and more
   
  September 08, 2023
  Tickers 
   RH
  
  
  From CNBC.com News
 
   Stocks making the biggest moves before the bell: Kroger, DocuSign, Snowflake, Adobe and more
   
  September 08, 2023
  Tickers 
   RH
  
  
  From CNBC.com News
 
   Stocks making the biggest moves midday: AMC Entertainment, Mattel, Chevron, Spotify and more
   
  
  July 24, 2023
  From CNBC.com News
 
   Hepatitis C cure is not reaching overwhelming majority of patients due to financial barriers
   
  
  June 29, 2023
  From CNBC.com News
 From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 


